Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled heparin in ventilator-associated pneumonia
IRCT20140310016917N8Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in ventilator-associated pneumonia (VAP) comparing Nebulized heparin plus standard treatment with Placebo distilled water plus standard treatment (2 arms). Primary endpoints: Duration of antibiotic treatment, Procalcitonin level and 1 more. Started Jun 2019; status: completed.
02
Drugs
heparin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20140310016917N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140310016917N8.